Abstract

The ability to isolate rare live cells within a heterogeneous population based solely on visual criteria remains technically challenging, due largely to limitations imposed by existing sorting technologies. Here we present a new method that permits labeling cells of interest by attaching streptavidin-coated magnetic beads to their membranes using the lasers of a confocal microscope. A simple magnet allows highly-specific isolation of the labeled cells, which then remain viable and proliferate normally. As proof of principle, we tagged, isolated, and expanded individual cells based on three biologically-relevant visual characteristics: i) presence of multiple nuclei, ii) accumulation of lipid vesicles, and iii) ability to resolve ionizing radiation-induced DNA damage foci. Our method constitutes a rapid, efficient, and cost-effective approach for isolation and subsequent characterization of rare cells based on observable traits such as movement, shape, or location, which in turn can generate novel mechanistic insights into important biological processes.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Loïc Binan

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. François Bélanger

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Maxime Uriarte

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Jean François Lemay

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3540-1627
  5. Jean Christophe Pelletier De Koninck

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Joannie Roy

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. El Bachir Affar

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Elliot Drobetsky

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Hugo Wurtele

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Santiago Costantino

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    For correspondence
    santiago.costantino@umontreal.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2454-2635

Funding

Canadian Institutes of Health Research

  • El Bachir Affar
  • Elliot Drobetsky
  • Hugo Wurtele

Natural Sciences and Engineering Research Council of Canada

  • El Bachir Affar
  • Elliot Drobetsky
  • Hugo Wurtele
  • Santiago Costantino

Genome Canada

  • Santiago Costantino

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Binan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,213
    views
  • 328
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Loïc Binan
  2. François Bélanger
  3. Maxime Uriarte
  4. Jean François Lemay
  5. Jean Christophe Pelletier De Koninck
  6. Joannie Roy
  7. El Bachir Affar
  8. Elliot Drobetsky
  9. Hugo Wurtele
  10. Santiago Costantino
(2019)
Opto-magnetic capture of individual cells based on visual phenotypes
eLife 8:e45239.
https://doi.org/10.7554/eLife.45239

Share this article

https://doi.org/10.7554/eLife.45239

Further reading

    1. Cancer Biology
    Han V Han, Richard Efem ... Richard Z Lin
    Research Article

    Most human pancreatic ductal adenocarcinoma (PDAC) are not infiltrated with cytotoxic T cells and are highly resistant to immunotherapy. Over 90% of PDAC have oncogenic KRAS mutations, and phosphoinositide 3-kinases (PI3Ks) are direct effectors of KRAS. Our previous study demonstrated that ablation of Pik3ca in KPC (KrasG12D; Trp53R172H; Pdx1-Cre) pancreatic cancer cells induced host T cells to infiltrate and completely eliminate the tumors in a syngeneic orthotopic implantation mouse model. Now, we show that implantation of Pik3ca−/− KPC (named αKO) cancer cells induces clonal enrichment of cytotoxic T cells infiltrating the pancreatic tumors. To identify potential molecules that can regulate the activity of these anti-tumor T cells, we conducted an in vivo genome-wide gene-deletion screen using αKO cells implanted in the mouse pancreas. The result shows that deletion of propionyl-CoA carboxylase subunit B gene (Pccb) in αKO cells (named p-αKO) leads to immune evasion, tumor progression, and death of host mice. Surprisingly, p-αKO tumors are still infiltrated with clonally enriched CD8+ T cells but they are inactive against tumor cells. However, blockade of PD-L1/PD1 interaction reactivated these clonally enriched T cells infiltrating p-αKO tumors, leading to slower tumor progression and improve survival of host mice. These results indicate that Pccb can modulate the activity of cytotoxic T cells infiltrating some pancreatic cancers and this understanding may lead to improvement in immunotherapy for this difficult-to-treat cancer.

    1. Cancer Biology
    2. Immunology and Inflammation
    Almudena Mendez-Perez, Andres M Acosta-Moreno ... Esteban Veiga
    Short Report

    In this study, we present a proof-of-concept classical vaccination experiment that validates the in silico identification of tumor neoantigens (TNAs) using a machine learning-based platform called NAP-CNB. Unlike other TNA predictors, NAP-CNB leverages RNA-seq data to consider the relative expression of neoantigens in tumors. Our experiments show the efficacy of NAP-CNB. Predicted TNAs elicited potent antitumor responses in mice following classical vaccination protocols. Notably, optimal antitumor activity was observed when targeting the antigen with higher expression in the tumor, which was not the most immunogenic. Additionally, the vaccination combining different neoantigens resulted in vastly improved responses compared to each one individually, showing the worth of multiantigen-based approaches. These findings validate NAP-CNB as an innovative TNA identification platform and make a substantial contribution to advancing the next generation of personalized immunotherapies.